Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: Evaluation as independent risk factors and as surrogates for high maternal serum α-fetoprotein in estimating breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 12, 2000, Pages 1349-1355

  Richardson, Barbara E ^a   Peck, Jennifer D ^b   Wormuth, Jennifer K ^c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b IL   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADOLESCENT; ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; ODDS RATIO; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0034520506     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Characteristics of first pregnancy in relation to early breast cancer: A case-control study
2. Hypertension and risk of breast cancer
3. Pregnancy characteristics and maternal risk of breast cancer
4. Risks associated with an elevated maternal serum α-fetoprotein level
5. The association of early-onset fetal growth restriction, elevated maternal serum α-fetoprotein and the development of severe pre-eclampsia
6. The association between maternal serum α-fetoprotein and preterm birth, small for gestational age infants, preeclampsia and placental complications
7. α-fetoprotein elevation and proteinuric pre-eclampsia
8. Prognostic significance of unexplained elevated amniotic fluid α-fetoprotein
9. Elevated maternal serum α-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes
10. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and α-fetoprotein
11. Midtrimester n-terminal proatrial natriuretic peptide, free β hCG and α-fetoprotein in predicting preeclampsia
12. Prediction of pre-eclampsia with maternal mid-trimester total renin, Inhibin A, AFP and free β-hCG levels
13. Toxemia of pregnancy: Assessment of fetal distress by urinary estriol and circulating human placental lactogen and α-fetoprotein levels
14. Preeclampsia: An update
15. Chemistry and biology of α-fetoproteins
16. Estradiol-activated α-fetoprotein suppresses die uterotropic response to estrogens
17. Purification of α-fetoprotein from human cord serum with demonstration of its antiestrogenic activity
18. Pregnancy-altered breast cancer risk: Mediated by maternal serum AFP?
19. Inhibition of estrogen-dependent breast cancer growth by a reaction product of α-fetoprotein and estradiol
20. Human mammary tumor cell proliferation: Primary role of platelet-derived growth factor and possible synergism with human α-fetoprotein
21. Specific cytoplasmic α-fetoprotein binding protein in MCF-7 human breast cancer cells and primary breast cancer tissue
22. Human α-fetoprotein enhances epidermal growth factor proliferative activity upon porcine granulosa cells in monolayer culture
23. Levels of maternal serum α-fetoprotein (AFP) in pregnant women and subsequent risk of breast cancer
24. α-fetoprotein derived synthetic peptides: Assay of an estrogen-modifying regulatory segment
25. The California Child Health and Development Studies of the School of Public Health, University of California at Berkeley
26. Randomized recruitment in case-control studies
27. The design and analysis of case-control studies with biased sampling
28. Definition and classification of toxemias brought up-to-date
29. Stability of α-fetoprotein in stored and frozen thawed aliquots
30. In vitro stability of human α-fetoprotein
31. Robust locally weighted regression and smoothing scatterplots
32. Etiology and pathogenesis of preeclampsia: Current concepts
33. Immunobiology of preeclampsia
34. Preeclampsia. An excessive maternal inflammatory response to pregnancy
35. High polyunsaturated fatty acid, thromboxane A2, and α-fetoprotein concentrations at the human feto-maternal interface
36. Carrier-protein-mediated enhancement of fatty-acid binding and internalization in human T-lymphocytes
37. Human AFP inhibits cell proliferation and NK-like cytotoxic activity generated in autologous, but not in allogeneic mixed lymphocyte reactions